Three people getting blood transfusions at the hospital. Cancer
| 7 min read
CAR T has transformed treatment for some blood cancers, but manufacturing and healthcare system constraints still prevent many eligible patients from receiving it.
A back view of a crowded conference room with a large projector showing a science talk. Regulatory & Industry
| 5 min read
From computationally designed repertoires to AI-driven specificity prediction and multispecific therapeutics, antibody researchers are developing new ways to design molecules for the biology they need to influence.
A brain with DNA and synapse imagery. Rare & Genetic Diseases
| 4 min read
Researchers are developing new delivery technologies to bring gene therapies to the central nervous system safely and precisely.
DDN Weekly Rundown text in blue and whiteRegulatory & Industry
| 3 min read
New partnerships, an expedited IND program from the FDA, another Phase 3 win for a LSD-based anxiety drug, and more led the news this week.
A pink ceramic brain with blue cracks on a gray backgroundNeuroscience
| 2 min read
Patients often show symptoms about ten years earlier than usual. The new work pinpointed a genetic variant that makes it happen.

News

A snake coiled on a branch, symbolizing themes in recombinant antivenom development.
| 3 min read
DDN Weekly Rundown text on a blue background
| 4 min read
Blue-stained cells under microscope, illustrating molecular glue degraders
| 3 min read
An illustration of T-cells attacking a cancer cell.
| 3 min read
Glitter on black background.
| 7 min read
3D rendering of a brain labyrinth with ladders leading out.
| 4 min read

Cancer Research News

Molecular illustration of the amivantamab EGFR-MET bispecific antibody mechanism in EGFR exon 20 insertion NSCLC, showing simultaneous receptor binding, immune effector cell recruitment via the Fc region, and receptor internalization through membrane invagination.
Final PAPILLON data show amivantamab-vmjw plus chemotherapy reaches 34 months median OS, the longest reported in this historically treatment-resistant NSCLC subtype
A ProBioGen scientist in face shield and cryogenic gloves retrieves a cell vial tray from a liquid nitrogen storage unit during AGE1.CR.pIX GMP master cell bank operations.
Transgene expands a duck-cell-line license as its personalized cancer vaccines advance deeper into the clinic

Editor's Pick

An illustration of cells with orange nuclei and transparent cytoplasm
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
An illustration of bone marrow containing immune and hematopoietic stem cells
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation. 

Multimedia

Crystal Girod, Senior Product Manager at Beckman Coulter Life Sciences, featured in a “Tell Us What You Know” graphic titled “Making Lab Automation More Accessible,” alongside the Beckman Coulter Life Sciences logo.
Explore how advances in liquid handling are making automation more accessible, flexible, and practical for modern labs.
3D illustration of an antibody-drug conjugate with cytotoxic payloads attached to an antibody.
Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate activity and inform candidate selection.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Crystal Girod, Senior Product Manager at Beckman Coulter Life Sciences, featured in a “Tell Us What You Know” graphic titled “Making Lab Automation More Accessible,” alongside the Beckman Coulter Life Sciences logo.
Explore how advances in liquid handling are making automation more accessible, flexible, and practical for modern labs.
Puzzle pieces spelling “DATA” alongside connected icons representing data analysis, storage, and reporting.
Earlier insight into analytical data can help laboratories recognize emerging trends and maintain method performance over time.
3D illustration of an antibody-drug conjugate with cytotoxic payloads attached to an antibody.
Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate activity and inform candidate selection.